So-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease (SCD), according to a three-year study of adults who underwent the procedure at the National Institutes of Health (NIH).
PharmAla Biotech: CEO Letter to Shareholders | Psychedelic Invest
“I just did my MDMA-assisted therapy yesterday. This modality is going to save so many lives. I am so in awe of your generosity to